Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela

Apixaban (5 mg BID), dabigatran (150mg), and rivaroxaban (20 mg once daily) are 3 novel oral anticoagulants (NOACs) currently approved for stroke prevention in patients with atrial fibrillation (AF). Although warfarin remains the standard of care in Venezuela.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: Y Fernández Ávila, KC Garcia, S Garrido Lecca, BM Donato, A Juarez-Garcia Source Type: research